Effectiveness and Safety of Apixaban Vs Warfarin Among Venous Thromboembolism Patients Using Five US Databases: A Subgroup Analysis of Obesity

被引：0
|
作者：
Cohen, Alexander T.
Sah, Janvi
Lee, Theodore
Wygant, Gail
Rosenblatt, Lisa
Hlavacek, Patrick
Emir, Birol
Keshishian, Allison
Delinger, Rachel
Luo, Xuemei
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140453
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: a subgroup analysis of chronic liver disease
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1942 - 1942
  • [2] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: a subgroup analysis of age
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1941 - 1941
  • [3] Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
    Cohen, Alexander
    Sah, Janvi
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 11
  • [4] Safety and Effectiveness of Apixaban, LMWH, and Warfarin Among Venous Thromboembolism Patients with Active Cancer: A Retrospective Analysis Using Four US Claims Databases
    Cohen, Alexander T.
    Keshishian, Allison
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Mardekian, Jack
    Wiederkehr, Daniel
    Sah, Janvi
    Luo, Xuemei
    BLOOD, 2019, 134
  • [5] Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race
    Cohen, A.
    Sah, J.
    Dhamane, A.
    Lee, T.
    Rosenblatt, L.
    Hlavacek, P.
    Emir, B.
    Keshishian, A.
    Yuce, H.
    Luo, X.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1940 - 1940
  • [6] Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Lee, Theodore
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    PLOS ONE, 2022, 17 (09):
  • [7] The comparative effectiveness and safety of warfarin, rivaroxaban, and apixaban in patients with venous thromboembolism: An analysis of three real-world US healthcare databases
    Iyer, Geetha
    Tesfaye, Helen
    Brill, Gregory
    Zakoul, Heidi
    Schneeweiss, Sebastian
    Bykov, Katsiaryna
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 11 - 12
  • [8] Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale
    Cohen, Alexander T.
    Keshishian, Allison
    Lee, Theodore
    Wygant, Gail
    Rosenblatt, Lisa
    Hlavacek, Patrick
    Mardekian, Jack
    Wiederkehr, Daniel
    Sah, Janvi
    Luo, Xuemei
    BLOOD, 2019, 134
  • [9] Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
    Alexander T. Cohen
    Janvi Sah
    Amol D. Dhamane
    Dionne M. Hines
    Theodore Lee
    Lisa Rosenblatt
    Birol Emir
    Allison Keshishian
    Huseyin Yuce
    Xuemei Luo
    Advances in Therapy, 2023, 40 (4) : 1705 - 1735
  • [10] Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
    Cohen, Alexander T.
    Sah, Janvi
    Dhamane, Amol D.
    Hines, Dionne M.
    Lee, Theodore
    Rosenblatt, Lisa
    Emir, Birol
    Keshishian, Allison
    Yuce, Huseyin
    Luo, Xuemei
    ADVANCES IN THERAPY, 2023, 40 (04) : 1705 - 1735
12345